Novel humanized anti-Nav1.7 antibodies with long-lasting, side-effect-free analgesic effects
Sosuke Yoneda, Daisuke Uta, Kana Yasufuku…·Erika Kasai
This study develops humanized anti-Nav1.7 antibodies that show long-lasting analgesic effects without side effects in neuropathic pain models.